William L Mullen, MD
Cardiovascular Disease (Cardiology) · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: St Johns Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mullen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Johns Medical CenterJackson, WYAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Saint Johns HealthPatients rate it 5 of 5 · 85% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for St Johns Medical Center
Behind the star rating — Deaths: 1 better, 3 the same, 0 worse of 4 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.05) · 207 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.2 (0.74 to 1.66) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.4 · 112 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 526 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,323 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.43 (0.99 to 5.87) · 358 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 204 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.51 to 3.86) · 346 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.68 (0 to 16.89) · 205 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.68 (0.58 to 8.79) · 190 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.59 (0.43 to 2.75) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 60 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 61 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -45.2 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -36.5 · 128 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 7.9) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.5 (8 to 16.3) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.3) · 836 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 359 cases | No different | Jan 2024 – Dec 2024 |
What patients said (409 patients answered, 29% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 85% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 80% |
| Doctors "always" listened carefully | 85% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 84% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 83% |
| Nurses "always" listened carefully | 83% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 71% |
| "YES", patients would definitely recommend the hospital | 85% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Original Medicare doctor bills
$95,331
Medicare paid this office $95,331 for 834 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 303 | $37,033 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 399 | $19,906 | $49 |
| New patient visit (60+ min) | 90 | $13,560 | $151 |
| Long return visit (40+ min) | 59 | $8,576 | $128 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 64 | $2,774 | $21 |
See all 15 services
| Return visit (30+ min) | 303 | $37,033 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 399 | $19,906 | $49 |
| New patient visit (60+ min) | 90 | $13,560 | $151 |
| Long return visit (40+ min) | 59 | $8,576 | $128 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 64 | $2,774 | $21 |
| New patient visit (45+ min) | 22 | $2,603 | $118 |
| Short return visit (20+ min) | 31 | $2,123 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,276 | $91 |
| External shock to heart to regulate heart beat | 12 | $1,233 | $82 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 63 | $1,173 | $18 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,119 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 69 | $800 | $10 |
| Insertion of needle into vein for collection of blood sample | 36 | $329 | $8 |
| Ultrasound of heart, follow-up | 15 | $286 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 20 | $268 | $13 |
Who their Medicare patients are
834 Original Medicare patients in 2024. Average age 76 · Women 42% · Also on Medicaid 3% · Health risk score 1.03. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 71% · Coronary heart disease 42% · Atrial fibrillation 36% · Heart failure 26% · Diabetes 17% · Cancer 16% · COPD 16% · Chronic kidney disease 13% · Depression 13% · Stroke 11% · Dementia 6%.
The office billed $579,235, Medicare allowed $132,597 and paid $95,331; for 1,505 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 834 | 1,505 | 76 | 1.03 | $579,235 | $95,331 |
| 2023 | 810 | 1,494 | 76 | 1.02 | $551,080 | $91,627 |
| 2022 | 835 | 1,572 | 76 | 0.96 | $542,644 | $96,522 |
| 2021 | 882 | 1,998 | 75 | 1.00 | $576,121 | $107,027 |
| 2020 | 857 | 1,944 | 75 | 1.05 | $646,458 | $111,058 |
| 2019 | 738 | 1,771 | 75 | 1.08 | $640,474 | $115,566 |
| 2018 | 639 | 1,663 | 75 | 1.18 | $443,816 | $112,343 |
| 2017 | 1,341 | 1,999 | 77 | 1.22 | $512,671 | $144,340 |
| 2016 | 1,699 | 2,474 | 77 | 1.26 | $746,928 | $204,789 |
| 2015 | 1,551 | 2,347 | 77 | 1.31 | $743,474 | $215,575 |
| 2014 | 1,433 | 2,085 | 77 | 1.13 | $726,569 | $206,916 |
| 2013 | 1,037 | 1,655 | 77 | 1.13 | $583,636 | $156,200 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 270 | $29,306 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 379 | $18,786 | $49 |
| New patient visit (60+ min) | 110 | $16,989 | $154 |
| Long return visit (40+ min) | 80 | $13,306 | $128 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 59 | $2,764 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,670 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,194 | $25 |
| External shock to heart to regulate heart beat | 12 | $1,177 | $84 |
| Short return visit (20+ min) | 16 | $1,106 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 98 | $1,067 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 42 | $790 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 36 | $379 | $11 |
| Ultrasound of heart, follow-up | 14 | $329 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $239 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 19 | $229 | $12 |
| Insertion of needle into vein for collection of blood sample | 23 | $202 | $8 |
2022: 13 services
| Return visit (30+ min) | 284 | $32,183 | $91 |
| New patient visit (60+ min) | 117 | $18,735 | $160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 344 | $18,109 | $51 |
| Long return visit (40+ min) | 74 | $12,162 | $138 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 167 | $2,566 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 168 | $1,730 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,529 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,445 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 81 | $914 | $11 |
| Short return visit (20+ min) | 16 | $893 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $461 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 33 | $457 | $14 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 14 | $274 | $20 |
2021: 18 services
| Return visit (30+ min) | 341 | $43,677 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 343 | $18,224 | $51 |
| New patient visit (60+ min) | 84 | $13,877 | $165 |
| Long return visit (40+ min) | 30 | $4,391 | $146 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 228 | $3,558 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 77 | $3,007 | $17 |
| New patient visit (45+ min) | 23 | $2,923 | $127 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 229 | $2,363 | $10 |
| Programming of dual lead pacemaker system | 30 | $2,136 | $59 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 23 | $1,939 | $17 |
| Short return visit (20+ min) | 23 | $1,692 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,647 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 65 | $775 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $685 | $57 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 12 | $517 | $37 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 27 | $387 | $14 |
| Ultrasound of heart, follow-up | 11 | $306 | $20 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $282 | $13 |
2020: 18 services
| Return visit (30+ min) | 364 | $41,207 | $78 |
| New patient visit (60+ min) | 140 | $20,711 | $148 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 335 | $20,548 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 193 | $3,271 | $17 |
| New patient visit (45+ min) | 26 | $3,016 | $116 |
| Long return visit (40+ min) | 22 | $2,504 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,244 | $160 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 196 | $2,215 | $11 |
| Short return visit (20+ min) | 38 | $2,031 | $51 |
| Programming of dual lead pacemaker system | 30 | $1,716 | $57 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,631 | $82 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 54 | $1,221 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 78 | $1,056 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 46 | $979 | $21 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $701 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 23 | $478 | $21 |
| Ultrasound of heart, follow-up | 14 | $421 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $335 | $22 |
2019: 13 services
| Return visit (30+ min) | 328 | $43,075 | $81 |
| New patient visit (60+ min) | 141 | $21,934 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $16,130 | $57 |
| New patient visit (45+ min) | 72 | $8,487 | $118 |
| Short return visit (20+ min) | 103 | $6,417 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,069 | $163 |
| Long return visit (40+ min) | 41 | $3,960 | $97 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 148 | $2,616 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 151 | $1,962 | $12 |
| External shock to heart to regulate heart beat | 15 | $1,366 | $85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 108 | $1,274 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 49 | $1,046 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 21 | $453 | $21 |
2018: 14 services
| Return visit (30+ min) | 255 | $35,806 | $79 |
| New patient visit (60+ min) | 153 | $23,455 | $153 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 338 | $20,386 | $57 |
| New patient visit (45+ min) | 55 | $6,616 | $120 |
| Long return visit (40+ min) | 52 | $5,710 | $110 |
| Short return visit (20+ min) | 79 | $5,127 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,406 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 122 | $1,650 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 35 | $1,245 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,227 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 59 | $693 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 32 | $567 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $411 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $230 | $18 |
2017: 14 services
| Return visit (30+ min) | 404 | $46,088 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 92 | $18,915 | $206 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 270 | $14,234 | $50 |
| New patient visit (60+ min) | 85 | $13,607 | $160 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 51 | $12,960 | $254 |
| Long return visit (40+ min) | 78 | $8,915 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 453 | $6,166 | $13 |
| New patient visit (45+ min) | 42 | $5,528 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,875 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,653 | $93 |
| Short return visit (20+ min) | 18 | $1,064 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $935 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 59 | $498 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $166 | $12 |
2016: 15 services
| Return visit (30+ min) | 323 | $55,024 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $52,528 | $218 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 130 | $33,155 | $251 |
| Long return visit (40+ min) | 123 | $17,693 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 638 | $9,821 | $15 |
| New patient visit (60+ min) | 54 | $9,732 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,666 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,350 | $178 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 260 | $2,340 | $8 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,166 | $80 |
| External ekg recording for more than 48 hours up to 21 days | 39 | $1,086 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 39 | $933 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $688 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $334 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $209 | $13 |
2015: 19 services
| Return visit (30+ min) | 340 | $68,876 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 244 | $56,294 | $229 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 113 | $30,292 | $268 |
| New patient visit (60+ min) | 55 | $10,816 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,439 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 496 | $8,006 | $16 |
| Long return visit (40+ min) | 47 | $6,425 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $6,061 | $87 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $3,201 | $246 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 226 | $1,951 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,907 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $962 | $60 |
| External ekg recording for more than 48 hours up to 21 days | 32 | $879 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 31 | $768 | $25 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $680 | $57 |
| Influenza vaccine split virus, preservative free | 15 | $534 | $36 |
| Administration of influenza virus vaccine | 16 | $507 | $32 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $362 | $28 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $288 | $14 |
2014: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 245 | $55,725 | $222 |
| Return visit (30+ min) | 307 | $53,051 | $91 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 142 | $38,452 | $269 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 54 | $13,272 | $241 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 538 | $7,849 | $14 |
| New patient visit (60+ min) | 39 | $7,114 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $6,839 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,461 | $176 |
| Long return visit (40+ min) | 38 | $5,221 | $131 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,305 | $79 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $1,026 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $887 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 82 | $833 | $8 |
| Hospital discharge day management, 30 minutes or less | 11 | $720 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $500 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $195 | $12 |
2013: 18 services
| Return visit (30+ min) | 310 | $56,717 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 189 | $35,605 | $187 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 102 | $23,383 | $229 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 44 | $6,452 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 326 | $5,546 | $17 |
| Long return visit (40+ min) | 40 | $5,237 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,972 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,078 | $89 |
| New patient visit (60+ min) | 19 | $3,482 | $183 |
| Short return visit (20+ min) | 11 | $744 | $68 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $707 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 47 | $479 | $7 |
| Administration of influenza virus vaccine | 11 | $334 | $30 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $323 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $218 | $20 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $165 | $13 |
| Injection, dobutamine hydrochloride, per 250 mg | 17 | $101 | None |
Drugs they prescribed that Part D paid
$592,722
Pharmacies billed $592,722 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,504 generic and 599 brand-name prescriptions · $592,722 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 198 | $210,393 | $1,063 |
| Xarelto | 87 | $96,748 | $1,112 |
| Repatha Sureclick | 106 | $76,470 | $721 |
| Entresto | 39 | $46,319 | $1,188 |
| Mounjaro | 31 | $36,330 | $1,172 |
See all 31 drugs
| Eliquis | 198 | $210,393 | $1,063 |
| Xarelto | 87 | $96,748 | $1,112 |
| Repatha Sureclick | 106 | $76,470 | $721 |
| Entresto | 39 | $46,319 | $1,188 |
| Mounjaro | 31 | $36,330 | $1,172 |
| Repatha | 42 | $30,744 | $732 |
| Praluent | 52 | $27,530 | $529 |
| Jardiance | 17 | $25,270 | $1,486 |
| Metoprolol | 248 | $3,872 | $16 |
| Atorvastatin | 209 | $2,577 | $12 |
| Eplerenone | 25 | $1,982 | $79 |
| Rosuvastatin | 129 | $1,736 | $13 |
| Losartan | 144 | $1,734 | $12 |
| Flecainide Acetate | 30 | $1,497 | $50 |
| Potassium Chloride | 38 | $1,096 | $29 |
| Lisinopril | 50 | $810 | $16 |
| Ezetimibe | 31 | $763 | $25 |
| Diltiazem 24hr Er (Xr) | 22 | $715 | $32 |
| Carvedilol | 76 | $651 | $9 |
| Amlodipine Besylate | 94 | $580 | $6 |
| Amiodarone | 34 | $579 | $17 |
| Clopidogrel | 34 | $500 | $15 |
| Spironolactone | 40 | $485 | $12 |
| Spironolactone-Hctz | 13 | $431 | $33 |
| Pravastatin | 21 | $408 | $19 |
| Sotalol | 16 | $350 | $22 |
| Furosemide | 34 | $261 | $8 |
| Hydrochlorothiazide | 35 | $254 | $7 |
| Diltiazem 24hr Er (Cd) | 17 | $229 | $13 |
| Metformin | 25 | $147 | $6 |
| Metoprolol | 20 | $129 | $6 |
Year by year
| 2024 | 2,103 | 368 | None | 28% | $592,722 |
| 2023 | 1,870 | 323 | 0% (0) | None | $494,623 |
| 2022 | 1,736 | 316 | 0% (0) | 25% | $406,941 |
| 2021 | 1,834 | 298 | 0% (0) | 22% | $333,304 |
| 2020 | 2,047 | 304 | None | 21% | $311,114 |
| 2019 | 2,003 | 290 | 0% (0) | 21% | $234,533 |
| 2018 | 2,198 | 389 | 0% (0) | 23% | $205,266 |
| 2017 | 3,416 | 436 | 0% (0) | 20% | $212,337 |
| 2016 | 3,249 | 373 | None | 20% | $200,579 |
| 2015 | 3,072 | 353 | 0% (0) | None | $154,218 |
| 2014 | 2,931 | 343 | None | None | $157,543 |
| 2013 | 3,359 | 355 | None | None | $178,393 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Eliquis | 193 | $195,342 | $1,012 |
| Xarelto | 96 | $108,211 | $1,127 |
| Repatha Sureclick | 49 | $41,184 | $840 |
| Mounjaro | 32 | $37,069 | $1,158 |
| Repatha | 34 | $29,188 | $858 |
| Entresto | 23 | $22,352 | $972 |
| Metoprolol | 201 | $3,892 | $19 |
| Atorvastatin | 194 | $3,155 | $16 |
| Losartan | 146 | $2,733 | $19 |
| Flecainide Acetate | 48 | $2,489 | $52 |
| Eplerenone | 18 | $2,334 | $130 |
| Diltiazem 24hr Er (Cd) | 21 | $1,875 | $89 |
| Rosuvastatin | 77 | $1,594 | $21 |
| Sotalol | 14 | $1,519 | $109 |
| Amiodarone | 37 | $1,386 | $37 |
| Potassium Chloride | 48 | $1,320 | $28 |
| Carvedilol | 102 | $1,278 | $13 |
| Ezetimibe | 29 | $1,044 | $36 |
| Amlodipine Besylate | 99 | $1,031 | $10 |
| Diltiazem 24hr Er (Xr) | 14 | $937 | $67 |
| Spironolactone | 46 | $767 | $17 |
| Lisinopril | 55 | $717 | $13 |
| Clopidogrel | 23 | $641 | $28 |
| Propranolol | 11 | $513 | $47 |
| Spironolactone-Hctz | 13 | $401 | $31 |
| Atenolol | 12 | $340 | $28 |
| Pravastatin | 19 | $311 | $16 |
| Metoprolol | 22 | $300 | $14 |
| Furosemide | 40 | $233 | $6 |
| Hydrochlorothiazide | 24 | $210 | $9 |
2022: 30 drugs
| Eliquis | 214 | $187,216 | $875 |
| Xarelto | 120 | $115,535 | $963 |
| Entresto | 31 | $25,936 | $837 |
| Repatha Sureclick | 18 | $14,071 | $782 |
| Repatha | 11 | $9,550 | $868 |
| Diltiazem 24hr Er (Cd) | 47 | $4,185 | $89 |
| Metoprolol | 159 | $3,980 | $25 |
| Atorvastatin | 188 | $3,508 | $19 |
| Flecainide Acetate | 36 | $3,028 | $84 |
| Ezetimibe | 30 | $2,466 | $82 |
| Rosuvastatin | 58 | $1,885 | $32 |
| Losartan | 115 | $1,850 | $16 |
| Eplerenone | 18 | $1,779 | $99 |
| Potassium Chloride | 62 | $1,468 | $24 |
| Carvedilol | 89 | $1,132 | $13 |
| Clopidogrel | 29 | $926 | $32 |
| Sotalol | 18 | $747 | $41 |
| Amiodarone | 23 | $714 | $31 |
| Amlodipine Besylate | 89 | $687 | $8 |
| Spironolactone-Hctz | 13 | $486 | $37 |
| Spironolactone | 51 | $480 | $9 |
| Pravastatin | 17 | $441 | $26 |
| Lisinopril | 44 | $429 | $10 |
| Propranolol | 16 | $396 | $25 |
| Digoxin | 13 | $373 | $29 |
| Metoprolol | 30 | $356 | $12 |
| Furosemide | 51 | $258 | $5 |
| Nitroglycerin | 11 | $155 | $14 |
| Atenolol | 12 | $116 | $10 |
| Hydrochlorothiazide | 15 | $63 | $4 |
2021: 30 drugs
| Eliquis | 188 | $164,926 | $877 |
| Xarelto | 84 | $86,930 | $1,035 |
| Entresto | 20 | $14,006 | $700 |
| Praluent | 14 | $11,217 | $801 |
| Repatha | 16 | $9,112 | $569 |
| Flecainide Acetate | 42 | $4,446 | $106 |
| Metoprolol | 142 | $3,411 | $24 |
| Atorvastatin | 208 | $3,326 | $16 |
| Diltiazem 24hr Er (Cd) | 39 | $2,723 | $70 |
| Potassium Chloride | 92 | $2,324 | $25 |
| Eplerenone | 26 | $1,792 | $69 |
| Carvedilol | 106 | $1,521 | $14 |
| Losartan | 112 | $1,392 | $12 |
| Rosuvastatin | 37 | $1,187 | $32 |
| Ezetimibe | 20 | $1,146 | $57 |
| Digoxin | 17 | $832 | $49 |
| Clopidogrel | 61 | $775 | $13 |
| Amlodipine Besylate | 99 | $670 | $7 |
| Pravastatin | 24 | $612 | $26 |
| Lisinopril | 69 | $569 | $8 |
| Sotalol | 22 | $526 | $24 |
| Spironolactone | 43 | $511 | $12 |
| Amiodarone | 27 | $464 | $17 |
| Metoprolol | 46 | $404 | $9 |
| Furosemide | 61 | $388 | $6 |
| Spironolactone-Hctz | 14 | $347 | $25 |
| Propranolol | 14 | $314 | $22 |
| Nitroglycerin | 12 | $139 | $12 |
| Atenolol | 16 | $137 | $9 |
| Hydrochlorothiazide | 14 | $76 | $5 |
2020: 30 drugs
| Eliquis | 196 | $145,348 | $742 |
| Xarelto | 108 | $86,845 | $804 |
| Repatha | 15 | $7,223 | $482 |
| Metoprolol | 191 | $5,376 | $28 |
| Flecainide Acetate | 40 | $5,068 | $127 |
| Atorvastatin | 243 | $3,844 | $16 |
| Diltiazem 24hr Er (Cd) | 28 | $3,772 | $135 |
| Potassium Chloride | 81 | $2,772 | $34 |
| Eplerenone | 24 | $2,181 | $91 |
| Losartan | 135 | $1,369 | $10 |
| Carvedilol | 115 | $1,153 | $10 |
| Pravastatin | 67 | $1,072 | $16 |
| Clopidogrel | 62 | $897 | $14 |
| Diltiazem 24hr Er | 23 | $828 | $36 |
| Cartia Xt | 17 | $814 | $48 |
| Amiodarone | 46 | $803 | $17 |
| Rosuvastatin | 22 | $753 | $34 |
| Spironolactone | 78 | $668 | $9 |
| Amlodipine Besylate | 82 | $614 | $7 |
| Sotalol | 19 | $503 | $26 |
| Ramipril | 11 | $464 | $42 |
| Spironolactone-Hctz | 17 | $431 | $25 |
| Furosemide | 74 | $356 | $5 |
| Lisinopril | 56 | $353 | $6 |
| Metoprolol | 57 | $337 | $6 |
| Torsemide | 11 | $249 | $23 |
| Nitroglycerin | 16 | $222 | $14 |
| Warfarin | 13 | $162 | $12 |
| Hydrochlorothiazide | 19 | $142 | $7 |
| Atenolol | 18 | $125 | $7 |
2019: 29 drugs
| Eliquis | 164 | $99,272 | $605 |
| Xarelto | 126 | $80,036 | $635 |
| Repatha | 11 | $6,010 | $546 |
| Metoprolol | 170 | $4,914 | $29 |
| Flecainide Acetate | 42 | $4,385 | $104 |
| Diltiazem 24hr Er (Cd) | 30 | $3,753 | $125 |
| Atorvastatin | 198 | $3,451 | $17 |
| Potassium Chloride | 115 | $3,135 | $27 |
| Amiodarone | 41 | $2,092 | $51 |
| Losartan | 150 | $1,497 | $10 |
| Carvedilol | 147 | $1,397 | $10 |
| Spironolactone | 79 | $805 | $10 |
| Cartia Xt | 18 | $714 | $40 |
| Clopidogrel | 47 | $689 | $15 |
| Rosuvastatin | 19 | $647 | $34 |
| Dilt-Xr | 18 | $646 | $36 |
| Pravastatin | 45 | $585 | $13 |
| Furosemide | 122 | $577 | $5 |
| Eplerenone | 11 | $559 | $51 |
| Diltiazem 24hr Er | 14 | $474 | $34 |
| Lisinopril | 68 | $385 | $6 |
| Amlodipine Besylate | 63 | $319 | $5 |
| Metoprolol | 56 | $277 | $5 |
| Sotalol | 15 | $276 | $18 |
| Hydrochlorothiazide | 32 | $217 | $7 |
| Nitroglycerin | 15 | $203 | $14 |
| Warfarin | 20 | $194 | $10 |
| Simvastatin | 13 | $170 | $13 |
| Atenolol | 16 | $78 | $5 |
2018: 32 drugs
| Eliquis | 151 | $81,605 | $540 |
| Xarelto | 77 | $47,432 | $616 |
| Repatha | 14 | $15,815 | $1,130 |
| Entresto | 14 | $6,579 | $470 |
| Metoprolol | 184 | $6,417 | $35 |
| Prasugrel | 12 | $4,849 | $404 |
| Atorvastatin | 282 | $4,579 | $16 |
| Diltiazem 24hr Er (Cd) | 35 | $3,603 | $103 |
| Potassium Chloride | 85 | $2,469 | $29 |
| Rosuvastatin | 41 | $2,271 | $55 |
| Flecainide Acetate | 31 | $2,068 | $67 |
| Carvedilol | 178 | $1,499 | $8 |
| Lisinopril | 124 | $894 | $7 |
| Losartan | 108 | $849 | $8 |
| Cartia Xt | 16 | $758 | $47 |
| Furosemide | 167 | $653 | $4 |
| Dilt-Xr | 11 | $584 | $53 |
| Pravastatin | 23 | $520 | $23 |
| Amlodipine Besylate | 74 | $497 | $7 |
| Amiodarone | 33 | $427 | $13 |
| Spironolactone | 52 | $412 | $8 |
| Warfarin | 17 | $392 | $23 |
| Clopidogrel | 39 | $378 | $10 |
| Levothyroxine | 16 | $359 | $22 |
| Isosorbide Mononitrate Er | 13 | $352 | $27 |
| Metoprolol | 62 | $342 | $6 |
| Simvastatin | 41 | $318 | $8 |
| Hydrochlorothiazide | 47 | $310 | $7 |
| Diltiazem | 14 | $230 | $16 |
| Lisinopril-Hydrochlorothiazide | 17 | $206 | $12 |
| Nitroglycerin | 11 | $195 | $18 |
| Atenolol | 23 | $108 | $5 |
2017: 41 drugs
| Eliquis | 117 | $65,359 | $559 |
| Xarelto | 78 | $52,904 | $678 |
| Metoprolol | 275 | $11,435 | $42 |
| Coreg Cr | 47 | $9,990 | $213 |
| Atorvastatin | 496 | $9,086 | $18 |
| Potassium Chloride | 93 | $4,047 | $44 |
| Rosuvastatin | 38 | $3,459 | $91 |
| Carvedilol | 244 | $2,248 | $9 |
| Eplerenone | 22 | $1,906 | $87 |
| Lisinopril | 239 | $1,878 | $8 |
| Valsartan | 40 | $1,815 | $45 |
| Amiodarone | 41 | $1,659 | $40 |
| Pravastatin | 78 | $1,576 | $20 |
| Digoxin | 27 | $1,368 | $51 |
| Cartia Xt | 30 | $1,298 | $43 |
| Amlodipine Besylate | 166 | $1,291 | $8 |
| Furosemide | 216 | $1,148 | $5 |
| Losartan | 123 | $1,134 | $9 |
| Nitroglycerin | 52 | $1,051 | $20 |
| Diltiazem 24hr Er | 26 | $1,046 | $40 |
| Isosorbide Mononitrate Er | 39 | $941 | $24 |
| Atenolol | 78 | $917 | $12 |
| Warfarin | 46 | $912 | $20 |
| Digox | 12 | $861 | $72 |
| Dilt-Xr | 17 | $845 | $50 |
| Metoprolol | 103 | $822 | $8 |
| Simvastatin | 108 | $808 | $7 |
| Clopidogrel | 62 | $757 | $12 |
| Bumetanide | 21 | $632 | $30 |
| Hydrochlorothiazide | 75 | $617 | $8 |
| Diltiazem Er | 18 | $579 | $32 |
| Irbesartan | 16 | $508 | $32 |
| Spironolactone | 69 | $474 | $7 |
| Lovastatin | 18 | $392 | $22 |
| Doxazosin Mesylate | 11 | $379 | $34 |
| Klor-Con 10 | 15 | $364 | $24 |
| Levothyroxine | 19 | $357 | $19 |
| Triamterene-Hydrochlorothiazid | 19 | $235 | $12 |
| Diltiazem | 11 | $209 | $19 |
| Lisinopril-Hydrochlorothiazide | 19 | $188 | $10 |
| Amoxicillin | 12 | $50 | $4 |
2016: 44 drugs
| Xarelto | 86 | $52,073 | $605 |
| Eliquis | 83 | $38,299 | $461 |
| Coreg Cr | 24 | $10,054 | $419 |
| Crestor | 21 | $9,951 | $474 |
| Metoprolol | 224 | $9,314 | $42 |
| Atorvastatin | 415 | $8,884 | $21 |
| Potassium Chloride | 109 | $6,894 | $63 |
| Amiodarone | 40 | $4,616 | $115 |
| Carvedilol | 203 | $2,443 | $12 |
| Lisinopril | 201 | $2,164 | $11 |
| Valsartan | 38 | $2,146 | $56 |
| Pravastatin | 75 | $1,804 | $24 |
| Nitrostat | 54 | $1,284 | $24 |
| Losartan | 120 | $1,283 | $11 |
| Amlodipine Besylate | 161 | $1,202 | $7 |
| Simvastatin | 107 | $1,154 | $11 |
| Furosemide | 193 | $1,134 | $6 |
| Digox | 19 | $1,131 | $60 |
| Warfarin | 53 | $1,104 | $21 |
| Atenolol | 130 | $1,102 | $8 |
| Digoxin | 34 | $1,044 | $31 |
| Clopidogrel | 67 | $975 | $15 |
| Bumetanide | 34 | $919 | $27 |
| Spironolactone-Hctz | 14 | $880 | $63 |
| Diltiazem 24hr Er | 25 | $852 | $34 |
| Metoprolol | 101 | $832 | $8 |
| Isosorbide Mononitrate Er | 40 | $831 | $21 |
| Dilt-Xr | 14 | $825 | $59 |
| Eplerenone | 17 | $793 | $47 |
| Cartia Xt | 22 | $766 | $35 |
| Doxazosin Mesylate | 13 | $753 | $58 |
| Lovastatin | 32 | $685 | $21 |
| Klor-Con 10 | 21 | $515 | $25 |
| Levothyroxine | 23 | $503 | $22 |
| Spironolactone | 61 | $480 | $8 |
| Hydrochlorothiazide | 55 | $474 | $9 |
| Diltiazem 24hr Cd | 12 | $464 | $39 |
| Triamterene-Hydrochlorothiazid | 31 | $461 | $15 |
| Diltiazem Er | 14 | $438 | $31 |
| Irbesartan | 22 | $406 | $18 |
| Benazepril | 18 | $321 | $18 |
| Nitroglycerin | 14 | $242 | $17 |
| Lisinopril-Hydrochlorothiazide | 13 | $103 | $8 |
| Amoxicillin | 14 | $26 | $2 |
2015: 42 drugs
| Xarelto | 75 | $39,969 | $533 |
| Metoprolol | 267 | $12,860 | $48 |
| Coreg Cr | 31 | $8,562 | $276 |
| Crestor | 26 | $8,366 | $322 |
| Atorvastatin | 362 | $7,451 | $21 |
| Eliquis | 16 | $7,131 | $446 |
| Valsartan | 48 | $5,814 | $121 |
| Diovan | 14 | $5,283 | $377 |
| Potassium Chloride | 121 | $4,721 | $39 |
| Niacin Er | 11 | $4,183 | $380 |
| Amiodarone | 34 | $3,601 | $106 |
| Pravastatin | 81 | $2,248 | $28 |
| Carvedilol | 175 | $1,817 | $10 |
| Lisinopril | 205 | $1,660 | $8 |
| Eplerenone | 17 | $1,656 | $97 |
| Warfarin | 60 | $1,409 | $23 |
| Digoxin | 39 | $1,383 | $35 |
| Atenolol | 129 | $1,329 | $10 |
| Simvastatin | 122 | $1,099 | $9 |
| Furosemide | 175 | $1,090 | $6 |
| Clopidogrel | 70 | $1,013 | $14 |
| Nitrostat | 55 | $1,012 | $18 |
| Spironolactone-Hctz | 14 | $890 | $64 |
| Diltiazem Er | 23 | $875 | $38 |
| Lovastatin | 49 | $851 | $17 |
| Metoprolol | 114 | $827 | $7 |
| Bumetanide | 21 | $785 | $37 |
| Irbesartan | 27 | $751 | $28 |
| Hydrochlorothiazide | 68 | $741 | $11 |
| Amlodipine Besylate | 104 | $728 | $7 |
| Cartia Xt | 20 | $698 | $35 |
| Diltiazem 24hr Cd | 32 | $689 | $22 |
| Losartan | 88 | $674 | $8 |
| Digox | 11 | $595 | $54 |
| Isosorbide Mononitrate Er | 32 | $495 | $15 |
| Triamterene-Hydrochlorothiazid | 24 | $457 | $19 |
| Klor-Con 10 | 23 | $378 | $16 |
| Levothyroxine | 16 | $325 | $20 |
| Spironolactone | 49 | $203 | $4 |
| Terazosin | 13 | $191 | $15 |
| Lisinopril-Hydrochlorothiazide | 14 | $115 | $8 |
| Benazepril | 11 | $115 | $10 |
2014: 41 drugs
| Xarelto | 78 | $36,371 | $466 |
| Metoprolol | 286 | $16,599 | $58 |
| Diovan | 45 | $14,477 | $322 |
| Atorvastatin | 326 | $10,276 | $32 |
| Crestor | 30 | $9,436 | $315 |
| Niacin Er | 15 | $5,512 | $367 |
| Eliquis | 16 | $3,916 | $245 |
| Potassium Chloride | 71 | $3,843 | $54 |
| Carvedilol | 216 | $3,093 | $14 |
| Eplerenone | 27 | $2,412 | $89 |
| Amiodarone | 21 | $2,153 | $103 |
| Lisinopril | 224 | $1,780 | $8 |
| Clopidogrel | 71 | $1,719 | $24 |
| Irbesartan | 16 | $1,611 | $101 |
| Klor-Con 10 | 59 | $1,534 | $26 |
| Warfarin | 87 | $1,530 | $18 |
| Simvastatin | 141 | $1,424 | $10 |
| Pravastatin | 38 | $1,282 | $34 |
| Digoxin | 30 | $1,280 | $43 |
| Spironolactone-Hctz | 30 | $1,231 | $41 |
| Digox | 21 | $1,074 | $51 |
| Losartan | 78 | $1,037 | $13 |
| Lovastatin | 57 | $982 | $17 |
| Amlodipine Besylate | 110 | $952 | $9 |
| Furosemide | 170 | $916 | $5 |
| Metoprolol | 125 | $868 | $7 |
| Cartia Xt | 18 | $793 | $44 |
| Hydrochlorothiazide | 53 | $757 | $14 |
| Atenolol | 79 | $691 | $9 |
| Nitrostat | 44 | $614 | $14 |
| Diltiazem 24hr Er | 16 | $608 | $38 |
| Diltiazem Er | 11 | $394 | $36 |
| Isosorbide Mononitrate Er | 13 | $305 | $23 |
| Benazepril | 20 | $296 | $15 |
| Klor-Con 8 | 11 | $295 | $27 |
| Enalapril Maleate | 16 | $264 | $16 |
| Losartan-Hydrochlorothiazide | 15 | $255 | $17 |
| Triamterene-Hydrochlorothiazid | 14 | $243 | $17 |
| Spironolactone | 25 | $214 | $9 |
| Terazosin | 21 | $187 | $9 |
| Quinapril | 11 | $92 | $8 |
2013: 44 drugs
| Diovan | 81 | $21,250 | $262 |
| Metoprolol | 365 | $20,257 | $55 |
| Xarelto | 49 | $18,856 | $385 |
| Atorvastatin | 336 | $14,127 | $42 |
| Niaspan | 30 | $9,970 | $332 |
| Pradaxa | 25 | $9,213 | $369 |
| Crestor | 31 | $8,713 | $281 |
| Lipitor | 21 | $8,124 | $387 |
| Carvedilol | 260 | $5,043 | $19 |
| Zetia | 12 | $4,875 | $406 |
| Potassium Chloride | 68 | $4,510 | $66 |
| Clopidogrel | 92 | $4,402 | $48 |
| Eplerenone | 34 | $3,885 | $114 |
| Losartan | 118 | $2,491 | $21 |
| Simvastatin | 149 | $1,941 | $13 |
| Coreg Cr | 13 | $1,913 | $147 |
| Lisinopril | 247 | $1,835 | $7 |
| Warfarin | 83 | $1,755 | $21 |
| Pravastatin | 63 | $1,562 | $25 |
| Amlodipine Besylate | 132 | $1,483 | $11 |
| Felodipine Er | 13 | $1,349 | $104 |
| Amiodarone | 22 | $1,238 | $56 |
| Metoprolol | 110 | $1,187 | $11 |
| Klor-Con 10 | 41 | $1,145 | $28 |
| Spironolactone-Hctz | 45 | $1,142 | $25 |
| Nitrostat | 66 | $1,067 | $16 |
| Lovastatin | 60 | $941 | $16 |
| Isosorbide Mononitrate Er | 36 | $926 | $26 |
| Hydrochlorothiazide | 61 | $902 | $15 |
| Atenolol | 81 | $855 | $11 |
| Furosemide | 164 | $827 | $5 |
| Diltiazem 24hr Cd | 25 | $822 | $33 |
| Klor-Con 8 | 18 | $761 | $42 |
| Diltiazem Er | 16 | $625 | $39 |
| Spironolactone | 41 | $497 | $12 |
| Benazepril | 25 | $473 | $19 |
| Triamterene-Hctz | 28 | $466 | $17 |
| Verapamil Er | 18 | $286 | $16 |
| Terazosin | 19 | $236 | $12 |
| Lisinopril-Hydrochlorothiazide | 20 | $226 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $222 | $19 |
| Digox | 20 | $201 | $10 |
| Digoxin | 12 | $121 | $10 |
| Bumetanide | 12 | $64 | $5 |
Money from drug and device companies
$73 in 2025
| 2025 | 3 | 4 | None | $73 |
| 2023 | 3 | 5 | None | $109 |
| 2022 | 3 | 4 | None | $122 |
| 2021 | 5 | 5 | None | $225 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Merlin@Home | $36 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $19 | 1 payment
|
| Boston Scientific | Watchman Flx | $17 | 1 payment
|
See all 4 published payments
| Abbott Laboratories | Meals · 2025-10-30 | Assurity | $16 |
| Abbott Laboratories | Meals · 2025-05-22 | Merlin@Home | $20 |
| Boston Scientific | Meals · 2025-05-19 | Watchman Flx | $17 |
| Regeneron Healthcare Solutions | Meals · 2025-02-18 | Dupixent | $19 |
See earlier years (2023, 2022, 2021)
2023: $109
| Boston Scientific | None | $55 | 3 payments
|
| CVRx | Barostim Neo System | $27 | 1 payment
|
| Abbott Laboratories | Merlin@Home | $27 | 1 payment
|
2022: $122
| Abbott Laboratories | Accent | $75 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $24 | 1 payment
|
| Amgen | Repatha | $22 | 1 payment
|
2021: $225
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $136 | 1 payment
|
| Myovant Sciences | Orgovyx | $32 | 1 payment
|
| Boston Scientific | Watchman | $27 | 1 payment
|
| Amgen | Repatha | $16 | 1 payment
|
| Lantheus Medical Imaging | Definity | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1457362329
- Licence
- WY 11229A
- Trained
- Tulane University School of Medicine, 1984
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WY 145965100
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2006-08-10
- NPI last updated
- 2025-10-22
- NPI record certified
- 2025-10-22
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.